3 February 2014 - Deborah Wilkes
Archived
Valeant Pharmaceuticals International is boosting its skincare business by acquiring US-based PreCision Dermatology in a deal worth around US$500 million.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.